research funding database


Research in Ulcerative Colitis 2024 (Europe, Australia, Canada)

Share this post

Logo of scientifyRESEARCH and Enago "Author First, Quality First" scientifyRESEARCH recommends English editing and author support services from Enago.
Text on a blue background says "Want to find funding & get support for grant-writing?" Logos of scientifyRESEARCH & GrantDesk appear below on a white background and an orange play symbol appears between the two logos. An arrow mark points to the logos.

The Research in Ulcerative Colitis (UC) grant from Pfizer supports global research that helps to address Ulcerative Colitis data gaps and advances the understanding of etrasimod and / or tofacitinib role in the treatment landscape.

Applicant must be affiliated with academic research institutions in Germany, Austria, Finland, Denmark, Norway, Netherlands, France, Italy, Spain, Switzerland, Belgium, Czech Republic, Canada, Australia, or the United Kingdom. The PI must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work.

Applicants may apply for up to 200,000 USD for 18 months (including 28% indirect costs).

Full applications are due on August 5, 2024.

Adverts. Premium members do not see Google Ads.

Please Login / Subscribe to our premium membership to see the content. Sign up to Free trial to see detailed funding information.

non member

Sign-up for the
monthly funding newsletter

unsubscribe at any time